Fate Therapeutics Secures $9,244,679 New Round

  • Feed Type
  • Date
    8/22/2012
  • Company Name
    Fate Therapeutics
  • Mailing Address
    3535 General Atomics Court San Diego, CA 92121
  • Company Description
    The company’s revolutionary platform focuses on both regenerative and reprogramming medicine. Fate’s regenerative medicine platform involves developing drugs that awaken adult stem cells in the body to repair damaged cells and tissues. Fate’s reprogramming medicine platform involves developing drugs to reprogram mature adult cells into stem cells which when differentiated can become healthy heart, bone, brain or other tissues.
  • Website
    http://www.fatetherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $9,244,679
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.